Beth Miller

Finished

Role of TRPV1 in Asthma Exacerbation

Lee, L. (PI), Collins, P. (CoI), Collins, B. (CoI), Khosravi, M. (CoI), Kryscio, R. (CoI), Miller, B. (CoI) & Snow, D. (Former CoI)

National Institute of Allergy and Infectious Diseases

1/15/16 → 12/31/20

Project: Research project

Role of TRPV1 in asthma exacerbation

Lee, L. (PI), Collins, P. (CoI), Collins, B. (CoI), Khosravi, M. (CoI), Kryscio, R. (CoI), Miller, B. (CoI) & Snow, D. (Former CoI)

National Institute of Allergy and Infectious Diseases

1/15/16 → 12/31/16

Project: Research project

Role of TRPV1 in Asthma Exacerbation

Lee, L. (PI), Collins, P. (CoI), Collins, B. (CoI), Khosravi, M. (CoI), Kryscio, R. (CoI), Miller, B. (CoI) & Snow, D. (Former CoI)

National Institute of Allergy and Infectious Diseases

1/15/16 → 12/31/17

Project: Research project

A 6-month safety and benefit study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of 6200 Pediatric Subjects 4-11 years old with Persistent Asthma

Miller, B. (PI)

Parexel International Co

12/24/12 → 6/30/14

Project: Research project

GSK MEA 115666 A multi-center, open-label, long term safety study of mepolizumab in asthmatic subjects whoparticipated in the MEA 112997 trial.

Miller, B. (PI)

GlaxoSmithKline

11/8/12 → 12/18/16

Project: Research project

A 12-Week Dose-ranging Study (TRUMPET)

Miller, B. (PI)

PPD Development Inc

7/1/12 → 4/30/14

Project: Research project

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma Who Completed a Prior Cephalon-Sponsored Study in Eosinophilic Asthma

Miller, B. (PI)

Cephalon Inc

4/26/11 → 5/31/15

Project: Research project

A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 years of age)

Miller, B. (PI)

Cephalon Inc

4/26/11 → 3/31/15

Project: Research project

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects with Severe Uncontrolled Refractory Asthma.

Miller, B. (PI)

GlaxoSmithKline

12/12/09 → 9/30/12

Project: Research project

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Long Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adult Subjects with a History of Ragweed Induced

Miller, B. (PI)

Schering Plough Co

10/1/09 → 9/30/11

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase III Study of the Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Administered as Allergen Based Tablets Once Daily to Adult Patients

Miller, B. (PI)

Quintiles Inc

1/1/09 → 12/31/11

Project: Research project

A Randomized Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter, Dose Ranging Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder Once Daily and Fluticasone Propionate Inhalation powder 250mcg Twice Daily

Miller, B. (PI), Holl, J. (CoI) & Temprano, J. (CoI)

GlaxoSmithKline

5/1/08 → 3/31/10

Project: Research project

A Randomized Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter, Dose Ranging Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder Once Daily and Fluticasone Propionate Inhalation powder 100mcg Twice Daily

Miller, B. (PI), Holl, J. (CoI) & Temprano, J. (CoI)

GlaxoSmithKline

4/1/08 → 3/31/10

Project: Research project

A Randomized Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter, Dose Ranging Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder Once Daily and Fluticasone Propionate Inhalation powder 500mcg Twice Daily

Miller, B. (PI), Holl, J. (CoI) & Temprano, J. (CoI)

GlaxoSmithKline

4/1/08 → 3/31/10

Project: Research project

A Phase IIIb Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Xolair in Subjects with Moderate to Severe Persistent Asthma who are Inadequately Controlled with High-Dose Inhaled Corticosteroids and Long-Acting Beta-Agonists

Miller, B. (PI)

Genentech Inc

9/1/06 → 6/30/10

Project: Research project

A 26 Week, Randomized, Double-Blind, Parallel-Group-Controlled, Multi-center Study To Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy In Patients With Persistent Allergic Asthma

Miller, B. (PI)

Novartis (domestic)

5/1/06 → 8/31/08

Project: Research project

A Multicenter, Randomized, Double-Blind, TRiple-Dummy, Placebo-Controlled, Parallel Group, Four-Weeek Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200mcg QD Versus Montelukast 10mg QD in Adolescent and Adult Subjects with

Miller, B. (PI)

GlaxoSmithKline

3/1/06 → 2/29/08

Project: Research project

An Epidemiologic Study of Xolair (Omalizumab): Evaluating Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS)

Miller, B. (PI)

Genentech Inc

7/29/04 → 4/30/12

Project: Research project

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients with Perennial Allergic Rhinitis

Miller, B. (PI) & THOMPSON, J. (CoI)

Merck and Company Inc

12/1/03 → 8/31/05

Project: Research project

A Double-Blind, Randomized, Placebo-Controlled Surveillance Study of Asthma Event Outcomes in Subjects Receiving Either Usual Pharmacotherapy of Asthma or Usual Pharmacotherapy Plus Salmeterol 42 mcg (2 Puffs) Twice Daily

Miller, B. (PI)

Glaxo Wellcome

10/13/00 → 2/28/02

Project: Research project

Beth Miller, MD

Projects & Grants

Search results